معرفی
Professor Hayden Homer is a leading authority in reproductive medicine and oocyte biology at the University of Queensland's UQ Centre for Clinical Research. Holding the fully endowed Christopher Chen Chair in Reproductive Medicine, he directs the Christopher Chen Oocyte Research Laboratory. With dual accreditation as a Subspecialist in Reproductive Medicine & Surgery (European Specialist Register) and Fellowship in Royal Australian NZ College of Obstetricians & Gynaecologists, his career spans clinical leadership at UCL Hospitals and UNSW before joining UQ in 2016.
- BMedSci (Hons) University of Newcastle
- PhD University of Newcastle-upon-Tyne
His research focuses on oocyte maturation, spindle assembly checkpoints, and NAD+ metabolome for fertility preservation, with transformative work in Science, Nature Communications, and Cell Reports. Key contributions include sirtuin regulation of oocyte quality, spindle dynamics, and aneuploidy mechanisms.
Recent publications highlight NAD+ repletion for chemotherapy-related fertility protection and Senataxin's role in delaying ovarian aging. His 2024 EMBO Molecular Medicine study demonstrated NAD(P)+ boosting as a fertility safeguard.
- NHMRC IDEAS Grant (2023-2027): Psychosocial burden of infertility treatment
- US CDMRP Grant (2023-2026): Endometriosis mouse model validation
- NHMRC Project Grants: NAD+ and Sirtuin2 in reproductive health (2016-2018)
As principal investigator in UCL's Mammalian Oocyte and Embryo Research Laboratory, he translated findings from mouse/human oocyte studies to clinical applications. Supervision of 2024 and 2020 PhD candidates reflects his mentorship in embryo imaging, asymmetric division, and metabolic interventions.
